| Literature DB >> 30857234 |
Indu Choudhary1, Du Hyeon Hwang2, Hyunkyoung Lee3, Won Duk Yoon4, Jinho Chae5, Chang Hoon Han6, Seungshic Yum7,8, Changkeun Kang9,10, Euikyung Kim11,12.
Abstract
Nowadays, proliferation of jellyfish has become a severe matter in many coastal areas around the world. Jellyfish Nemopilema nomurai is one of the most perilous organisms and leads to significant deleterious outcomes such as harm to the fishery, damage the coastal equipment, and moreover, its envenomation can be hazardous to the victims. Till now, the components of Nemopilema nomurai venom (NnV) are unknown owing to scant transcriptomics and genomic data. In the current research, we have explored a proteomic approach to identify NnV components and their interrelation with pathological effects caused by the jellyfish sting. Altogether, 150 proteins were identified, comprising toxins and other distinct proteins that are substantial in nematocyst genesis and nematocyte growth by employing two-dimensional gel electrophoresis and matrix-assisted laser desorption/ionization time of flight mass spectrometry (MALDI/TOF/MS). The identified toxins are phospholipase A2, phospholipase D Li Sic Tox beta IDI, a serine protease, putative Kunitz-type serine protease inhibitor, disintegrin and metalloproteinase, hemolysin, leukotoxin, three finger toxin MALT0044C, allergens, venom prothrombin activator trocarin D, tripeptide Gsp 9.1, and along with other toxin proteins. These toxins are relatively well characterized in the venoms of other poisonous species to induce pathogenesis, hemolysis, inflammation, proteolysis, blood coagulation, cytolysis, hemorrhagic activity, and type 1 hypersensitivity, suggesting that these toxins in NnV can also cause similar deleterious consequences. Our proteomic works indicate that NnV protein profile represents valuable source which leads to better understanding the clinical features of the jellyfish stings. As one of the largest jellyfish in the world, Nemopilema nomurai sting is considered to be harmful to humans due to its potent toxicity. The identification and functional characterization of its venom components have been poorly described and are beyond our knowledge. Here is the first report demonstrating the methodical overview of NnV proteomics research, providing significant information to understand the mechanism of NnV envenomation. Our proteomics findings can provide a platform for novel protein discovery and development of practical ways to deal with jellyfish stings on human beings.Entities:
Keywords: 2-DE; Jellyfish; MALDI/TOF/MS; Nemopilema nomurai; NnV
Mesh:
Substances:
Year: 2019 PMID: 30857234 PMCID: PMC6468547 DOI: 10.3390/toxins11030153
Source DB: PubMed Journal: Toxins (Basel) ISSN: 2072-6651 Impact factor: 4.546
Figure 1Image showing proteomic analysis of 2-DE of NnV. Representative 2-DE image of N. nomurai jellyfish venom (A). For the first dimension, 500 µg of proteins were resolved on an 18 cm, IPG dry strips (pH 3–10) and 12% SDS-PAGE gels were used to run second dimension. 2-DE gels were stained using the silver staining method and the Epson perfection V 700 photo scanner was used for scanning the stained gels. For statistical analysis, three independent replicate gels were run.
Figure 2The representative 2-DE image of NnV proteins generated by Progenesis Same Spots software. Boundaries and arrows signify the position of differentially expressed proteins. Putative numbers were assigned to each protein spot.
Protein identified in N. nomurai venom by using MALDI/TOF/MS.
| Spot No | Accession Number 1 | Protein Name | Uniprot ID | Therotical MW/Pi 2 | Organism | Matched Peptide 3 | MOWSE Score | Biological Process |
|---|---|---|---|---|---|---|---|---|
| 1450 | P23897 | Heat-stable enterotoxin recepter | GUC2C_RAT | 123,468/6.4 |
| 8% | 4851 | Intracellular signal, transduction, regulation of cell proliferation |
| 1053 | P55128 | RTX-I toxin determinant A from serotypes 1/9 | RTXII_ACTPL | 110,194/5.5 |
| 9.20% | 4636 | Hemolysis in other organism, pathogenesis |
| 1622 | P15321 | Hemolysin transporter, protein ShlB | HLYB_SERMA | 61,917/9.2 |
| 15.30% | 3414 | Hemolysis in other organism, pathogenesis protein transmembrane transport |
| 1260 | Q1W694 | Phospholipase D LiSicTox-betaIDI | B1Q_LOXIN | 34,831/7.6 |
| 22.00% | 154 | Pathogenesis, Hemolysis in other organism, phospholipid catabolic process |
| 1338 | P39673 | Allergen Mag (fragment) | MAG_DERFA | 39,668/6.9 |
| 11.70% | 320 | |
| 721 | P55123 | Leukotoxin | LKTA_PASSP | 101,560/5.6 | 8.40% | 1331 | Hemolysis in other organism, pathogenesis | |
| 1213 | B2BS84 | Putative Kunitz-type serine protease inhibitor | VKT_AUSLA | 27,571/7.9 |
| 25.00% | 7.14 × 102 | |
| 1486 | P0C845 | Turripeptide Gsp9.1 | C91_GEMSP | 9290/9.1 |
| 26.80% | 1802 | |
| 837 | F5CPD3 | Three-finger toxin MALT0044C | 3SX4_MICAT | 9398/8.4 |
| 54.10% | 8534 | Pathogenesis |
| 1643 | P81428 | Venom prothrombin activator trocarin-D | FAXD_TROCA | 51,407/8.1 |
| 9.90% | 294 | Blood coagulation, envenomation resulting in positive regulation of blood coagulation in other organism |
| 889 | P55130 | RTX-III toxin determinant A from serotype 2 | RTX31_ACTPL | 112,492/5.8 |
| 13.00% | 6.89 × 106 | Cytolysis, pathogenesis |
| 930 | O59824 | ATP-dependent zinc metalloprotease YME1 homolog | YME1_SCHPO | 78,219/8.5 | 6.20% | 1335 | proteolysis | |
| 1614 | Q7S9D2 | Pro-apoptotic serine protease nma111 | NM111_NEUCR | 113,312/5.7 |
| 10.80% | 30913 | Apoptotic process |
| 1182 | P08026 | Shiga-like toxin 1 subunit A | STXA_BPH19 | 34,800/9.6 | 21% | 2329 | negative regulation of translation, pathogenesis | |
| 1450 | Q2FZP2 | Serine protease HtrA-like | HTRAL_STAA8 | 86,460/6.5 | 20.20% | 876,777 | ||
| 1647 | E5AJX2 | Snake venom serine protease nikobin | VSP_VIPNI | 28,216/8.0 |
| 18.20% | 425 | |
| 801 | Q2QA02 | Zinc metalloproteinase-disintegrin-like alternative name Snake venom metalloproteinase | VM3_CRODD | 68,292/5.1 |
| 19.50% | 57,907 | |
| 1233 | Q40240 | Major pollen allergen Lol p 5a | MPA5A_LOLPR | 30,888/5.4 |
| 16.90% | 707 | type I hypersensitivity |
| 1339 | P54319 | Phospholipase A-2-activating protein | PLAP_RAT | 87,085/5.7 |
| 11.30% | 1961 | Inflammatory response |
| 1343 | P23636 | Major serine/threonine-protein phosphatase PP2A_2 catalytic subunit | PP2A2_SCHPO | 36,489/4.7 | 19.60% | 2620 | Cell division, signal transduction, mitotic nuclear division | |
| 1206 | Q9TT93 | A disintegrin and metallo-proteinase with thrombo-spondin motifs 4 | ATS4_BOVIN | 90,281/8.6 |
| 11.90% | 3.76 × 104 | Proteolysis, Angiogenesis |
| 1500 | P97570 | 85/88 kDa calcium-independent phospholipase A2 | PLPL_RAT | 89,556/6.7 |
| 12% | 19,976 | ATP dependent protein binding, chemotaxis, positive regulation of vasodilation |
| 1315 | P58459 | A disintegrin and metalloproteinase with thrombospondin motifs 10 | ATS10_MOUSE | 121,087/8.4 |
| 11.30% | 40,176 | Microfibrils assembly |
| 1382 | Q9R1V7 | A disintegrin and metalloproteinase with thrombospondin motifs 23 | ADA_23 MOUSE | 91,548/7.9 |
| 14% | 2773 | Cell adhesion |
| 1461 | Q9XWD6 | Cell death abnormality protein 1 | CED1_CAEEL | 118,805/5.5 |
| 10.10% | 6333 | Programmed cell death, apoptotic cell death, receptor-mediated endocytosis, |
| 1272 | Q9T051 | Phospholipase D gamma 2 | PLDG2_ARATH | 96,024/8.3 |
| 12.60% | 11,703 | Response to stress, membrane lipid metabolic process, phosphotidylcholine metabolic process |
| 1334 | Q10743 | A disintegrin and metalloproteinase with thrombospondin motifs 10 fragment | ADA10_RAT | 60,445/8.4 |
| 15.10% | 5386 | Negative regulation of cell adhesion, Notch signaling pathway, protein phosphorylation |
| 1498 | Q83XX3 | ATP-dependent zinc metalloprotease FtsH | FTSH_OENOE | 78,070/9.3 |
| 10.30% | 447 | Protein catabolic process |
| 867 | P78536 | Disintegrin and metalloproteinase domain-containing protein 17 | ADA17_HUMAN | 93,022/5.5 |
| 10.70% | 2397 | Positive regulation of cell growth and cell migration, negative regulation of transforming growth factor beta receptor signaling |
| 1434 | A8XEZ1 | Cell death abnormality protein 12 | CED12_CAEBR | 83,692/5.2 | 9.00% | 3371 | Engulfment of apoptotic cell, cell migration, apoptotic process, phagocytosis, positive regulation of GTPase activity | |
| 1558 | Q9S5Z2 | ATP-dependent Clp protease ATP-binding subunit ClpE | PLPL8_MOUSE | 87,382/9.3 |
| 9.10% | 2564 | Cell death, arachidonic acid, secretion, phosphatidylcholine catabolic process |
| 1418 | Q8K1N1 | Calcium-independent phospholipase A2-gamma | HTRAL_STAA8 | 86,460/6.5 | 20.20% | 876,777 | ||
| 1183 | O93654 | Tricorn protease-interacting factor F2 | NAS8_CAEEL | 46,096/5.8 |
| 13.40% | 104 | |
| 1087 | Q18439 | Zinc metalloproteinase nas-8 | CYM1_YEAST | 112,181/6.0 | 18.20% | 383,182 | Protein processing, proteolysis, 54 |
1 Accession numbers predicted by Swiss-Prot 2 Theoretical mass (MW) and Pi reported in Swiss-Prot 3 Percentage of amino acids sequence coverage of matched peptides for the identified proteins.
Figure 3Zymography identify Metalloproteinase and PLA2 activity in NnV. Different types of zymography assays were performed to determining proteolytic activity of NnV (2 mg/mL) using gelatin, casein, and fibrin as a substrate and copolymerized in non-reducing SDS-PAGE (A). Zymography assays were performed in the presence of a metalloproteinase inhibitor (1,10-phenanthroline, 10 mM) during the enzymatic reaction time. Comparison of SDS-PAGE and zymography of NnV under non-reducing conditions (B). NnV proteins (40 mg and 5 mg of total protein) were run on a 12% SDS gel and gels were Coomassie stained. M: Protein molecular size marker. Clear zones in the gel indicate regions of proteolytic activity.
Figure 4Comparison of 2-DE pattern and 2-DE gelatin zymogram of N. nomurai venom. The N. nomurai venom (500 µg) separated on 18 cm IPG dry strips (pH 3–10) in the first dimension then followed by second dimension (A). For the 2-DE gelatin zymography, the gels were copolymerized with gelatin and the second dimension was performed in a 12% SDS-PAGE gels under non-reducing conditions. Proteolytic activity is understood as clear zones of lysis against the dark background (B).
Figure 5Gene ontology analysis of the identified venom proteins according to their molecular functions, biological processes, cell components, and protein classes.
Figure 6Comparison of relative composition of N. nomurai venom according to protein families by a proteomics approach. The pie chart is showing relative abundance of different protein families identified by MALDI/TOF/MS in NnV.